Abstract
The search for ways to support the long-term cultivation of hematopoietic stem cells, their expansion, and studies of long-term growth kinetics and interactions of cells in normal and malignant processes remain among some of the most challenging issues of stem cell research. Solving these problems is one of the most important tasks of cell biology, biotechnology, and regenerative medicine. The analysis of features of proliferation and differentiation of the bone marrow derived from the patients with chronic myeloid leukemia and normal bone marrow in long-term culture of the original gel diffusion chambers implanted in the abdominal cavity of laboratory animals was conducted. The suspension culture in chambers of original design in vivo, the method of determining hematopoietic progenitor cells in semiliquid agar in vitro, cytological, and statistical methods were used. The results of the cultivation showed that the bone marrow cells of chronic myeloid leukemia (CML) patients with a detected Ph chromosome had a significant proliferative potential up to the 30th day in the culture, which was twice the normal value. Further on, the colony-forming activity declined rapidly in contrast to normal bone marrow, where active hematopoiesis was maintained for up to 1.5 months. The peculiarities in cell differentiation in clones were manifested as the predominance of erythroid progenitor cells in CML, while granulocyte-macrophage progenitor cells predominated under normal conditions. Thus, the proposed cultural system of long-term support of hematopoiesis provides an approach for studying normal human hematopoiesis and opens up prospects for addressing the nature of the transformed population of cells in malignant diseases of the hematopoietic system.






Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.REFERENCES
Abarrategi, A., Mian, S.A., Passaro, D., Rouault-Pierre, K., Grey, W., and Bonnet, D., Modeling the human bone marrow niche in mice: From host bone marrow engraftment to bioengineering approaches, J. Exp. Med., 2018, vol. 215, no. 3, pp. 729–743. https://doi.org/10.1084/jem.20172139
Abbonante, V., Di Buduo, C.A., Gruppi, C., Malara, A., Gianelli, U., Celesti, G., Anselmo, A., Laghi, L., Vercellino, M., Visai, L., Iurlo, A., Moratti, R., Barosi, G., Rosti, V., and Balduini, A., Thrombopoietin/TGF- beta1 loop regulates megakaryocyte extracellular matrix component synthesis, Stem Cells, 2016, vol. 34, no. 4, pp. 1123–1133. https://doi.org/10.1002/stem.2285
Acar, M., Kocherlakota, K.S., Murphy, M.M., Peyer, J.G., Oguro, H., Inra, C.N., Jaiyeola, C., Zhao, Z., Luby-Phelps, K., and Morrison, S.J., Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal, Nature, 2015, vol. 526, no. 7571, pp. 126–130. https://doi.org/10.1038/nature15250
Anthony, B. and Link, D., Regulation of hematopoietic stem cells by bone marrow stromal cells, Trends Immunol., 2014, vol. 35, no. 1, pp. 32–37. https://doi.org/10.1016/j.it.2013.10.002
Aqmasheh, S., Shamsasanjan, K., Akbarzadehlaleh, P., Pashoutan Sarvar, D., and Timari, H., Effects of mesenchymal stem cell derivatives on hematopoiesis and hematopoietic stem cells, Adv. Pharm. Bull., 2017, vol. 7, no. 2, pp. 165–177. https://doi.org/10.15171/apb.2017.021
Bilko, D., Method of long-term cultivation of hematopoietic stem cells, UA Patent no. 146819, 2021.
Bilko, D. and Chaikovsky, Y., The role of substrate stiffness in maintaining pluripotency of embryonic stem cells in vitro culture, Fiziol. Zh., 2021, vol. 67, no. 3, pp. 27–34.
Ch’avez-Gonz’alez, A., Ayala-S’anchez, M., Sanchez-Valle, E., Ruiz-Sanchez, E., Arana-Trejo, R.M., Vela-Ojeda, J., and Mayani, H., Functional integrity in vitro of hematopoietic progenitor cells from patients with chronic myeloid leukemia that have achieved hematological remission after different therapeutic procedures, Leukocyte Res., 2006, vol. 30, no. 3, pp. 286–295. https://doi.org/10.1016/j.leukres.2005.06.028
Chaikovsky, Y., Deltsova, O., and Gerashohenko, S., Stem Cells, Ivano-Frankivsk: Town NV, 2014.
Chowdhury, F., Li, Y., Chuin Poh, Y., Tamaki, T., Wang, N., and Tanaka, T., Soft substrates promote homogeneous self-renewal of embryonic stem cells via downregulating cell–matrix tractions, PLoS One, 2010, vol. 5, no. 12, art. e15655. https://doi.org/10.1371/journal.pone.0015655
Dexter, T.M., Allen, T., and Lajtha, L., Conditions controlling the proliferation of haemopoietic stem cells in vitro, J. Cell Physiol., 1977, vol. 91, no. 3, pp. 335–344. https://doi.org/10.1002/jcp.1040910303
Dexter, T.M. and Lajtha, L., Proliferation of haemopoietic stem cells in vitro, Br. J. Haematol., 1974, vol. 28, no. 4, pp. 525–530. https://doi.org/10.1111/j.1365-2141.1974.tb06671.x
Diachenko, M., Bilko, N., and Dyagil, I., Alterations in functional properties of bone marrow stem cells in chronic myeloid leukemia patients with different response to tyrosine kinase inhibitors treatment, Exp. Oncol., 2013, vol. 35, p. 135.
Gartner, S. and Kaplan, H., Long term culture of human bone marrow cells, Proc. Natl. Acad. Sci. U. S. A., 1980, vol. 77, no. 8, pp. 4756–4759. https://doi.org/10.1073/pnas.77.8.4756
Gluzman, D.F., Abramenko, I.V., Sklyarenko, L.M., and Nadgornaya, V.A., Laboratory Diagnosis of Onco-Hematological Diseases, Kiev: Morion, 1998.
Holyoake, T., Jiang, X., Drummond, M., Eaves, A., and Eaves, C., Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia, Leukemia, 2002, vol. 16, no. 4, pp. 549–558. https://doi.org/10.1038/sj.leu.2402444
Holzapfel, B., Hutmacher, D., Nowlan, B., Barbier, V., Thibaudeau, L., Theodoropoulos, C., Hooper, J., Loessner, D., Russell, C., Pettit, A., Winkler, I., and Levesque, J., Tissue engineered humanized bone supports human hematopoiesis in vivo, Biomaterials, 2015, vol. 61, pp. 103–114. https://doi.org/10.1016/j.biomaterials.2015.04.057
Kuznietsova, H., Dziubenko, N., Byelinska, I., Hurmach, V., Bychko, A., Lynchak, O., Milokhov, D., Khilya, O., and Rybalchenko, V., Pyrrole derivatives as potential anti-cancer therapeutics: synthesis, mechanisms of action, safety, J. Drug Target., 2020, vol. 28, no. 5, pp. 547–563. https://doi.org/10.1016/j.biomaterials.2015.04.057
Srour, E., Hofman, R., and Zanjan, E., Animal models for human hematopoiesis, J. Hematother., 1992, vol. 1, no. 2, pp. 143–153. https://doi.org/10.1089/scd.1.1992.1.143
Sviezhentseva, I., Perekhrestenko, T., Bilko, D., Gordienko, A., Diachenko, M., and Dyagil, I., Functional activity of 34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy, Exp. Oncol., 2015, vol. 37, no. 1, pp. 70–72.
Verfaillie, C., Miller, W., Boylan, K., and McGlave, P., Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression, Blood, 1992, vol. 9, no. 4, pp. 1003–1010.
Funding
The study was performed within the framework of financing a research project of the National University of Kyiv-Mohyla Academy, state registration no. 0119U103427.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest. The authors declare that they have no conflict of interests.
Statement on the welfare of animals. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. The study was approved by the Commission on Ethics and Bioethics of the National University of Kyiv-Mohyla Academy (Minutes no. 6 of May 11, 2017). All experimental manipulations were carried out in accordance with the Law of Ukraine “On Protection of Animals from Cruelty” of February 26, 2006, and the European Convention for the Protection of Vertebrate Animals Used for Research and Scientific Purposes (Strasbourg, 1986).
Additional information
Translated by V. Mittova
About this article
Cite this article
Bilko, D.I., Dyagil, I.S. & Chaikovsky, Y.B. Morphofunctional Features of Hematopoietic Bone Marrow Progenitor Cells in Patients with Chronic Myeloid Leukemia in Long-Term Culture of Gel Diffusion Chambers In Vivo. Cytol. Genet. 56, 9–15 (2022). https://doi.org/10.3103/S0095452722010030
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0095452722010030


